March 27, 2024 - Myeloma
Please note, access to symposium recordings is included with registration.
Access will be available for 30 days post event.
With several new drug and cellular therapies as well as an expansion of our understanding of the biologic heterogeneity of hematologic malignancies, there is a need for ongoing education in the area of hematologic malignancies. This interactive webinar series will focus on current best practices, and how those are evolving based on major updates in the biology, diagnosis, and management of hematologic malignancies. Attendee interaction is encouraged and promoted through the designated time for audience questions at the end of each webinar. Each 90-minute webinar will have two talks followed by discussion and audience Q&A. Presenters will include internationally-known disease experts from Mass General Cancer Center covering high-yield practice-changing updates in cellular therapies, transplant, myeloma, leukemia, and lymphoma.
This activity is intended for physicians, nurses, pharmacists, other members of healthcare team (regional) with specialties such as general practice, hematology, hematology/oncology, medical oncology, primary care, and radiation oncology.
Upon completion of this activity, participants will be able to:
- Discuss practice-changing updates in the management of multiple myeloma.
- Identify new therapies available for multiple myeloma.
Massachusetts General Hospital Cancer Center & Mass General Brigham
Practice-Changing Updates for Upfront Treatment of Myeloma
Practice-Changing Updates for Relapsed Myeloma
P. Connor Johnson, MD
|Andrew Yee, MD
Clinical Director, Center for Multiple Myeloma
Massachusetts General Hospital Cancer Center
Diana Cirstea, MD
In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statements
AMA PRA Category 1 CreditsTM
Mass General Brigham designates this live activity for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Mass General Brigham designates this activity for 1.5 ANCC contact hours. Nurses should only claim credit commensurate with the extent of their participation in the activity.
This activity provides 1.5 contact hours (1.5 CEUs) of continuing education credit. ACPE Universal Activity Number (UAN): JA0007437-0000-24-001-L01-P
This activity provides 1.5 contact hours (1.5 CEUs) of continuing education credit. ACPE Universal Activity Number (UAN): JA0007437-0000-24-001-L01-T
- 1.50 ACPE Pharmacy
- 1.50 ACPE Technician
- 1.50 AMA PRA Category 1 Credit™
- 1.50 Nursing Contact Hours
- 1.50 Participation
Registrations cancelled on or before March 13, 2024 will be refunded, less a $20 administrative fee. Registrations cancelled after March 13, 2024 will not be refunded.
Contact email@example.com if you require assistance in cancelling your online registration.